Skip to main content
Screener/Healthcare/Biotechnology

CCCC — C4 Therapeutics, Inc.

NASDAQ
$3.48+0.04 (+1.31%)
Small CapPenny StockUnder $5Healthcare
$1.69
$5.17
$3.44
$3.53
EPS (TTM)$-1.19
P/E Ratio-2.17
Dividend Yield—
Market Cap$388.1M
Volume143K
Prev Close$3.43
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$6.2M-$25.1M$-0.2070.7%-408.5%
Q4 '25$11.0M-$20.5M$-0.1883.6%-186.0%
Q3 '25$11.2M-$32.2M$-0.44100.0%-286.4%
Q2 '25$6.5M-$26.0M$-0.37100.0%-402.6%
Q1 '25$7.2M-$26.3M$-0.37100.0%-363.7%
Q4 '24$5.2M-$34.6M$-0.4965.9%-667.8%
Q3 '24$15.4M-$24.7M$-0.3586.6%-160.6%
Q2 '24$12.0M-$17.7M$-0.2683.0%-147.6%
Get Your Daily Market Recap